Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
Poor Early Anticoagulation Control Associated with Near 3-fold Increase in DVT Recurrence and Post-thrombotic Syndrome
Alex C. Spyropoulos, MD, FACP, FCCP
Review: van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost. 2005 May;3(5):939-42.
Van Dungen and colleagues evaluated 244 DVT patients on oral anticoagulation therapy (OAT). During a median follow-up of 4.9 years, and using a validated post-thrombotic syndrome (PTS) scoring system, they found that patients whose INRs were less than 2 more than 50% of the time were 2.7 times as likely to develop PTS (odds ratio 2.71, 95% confidence interval 1.44 - 5.10). Specifically, 81 patients (33%) developed PTS when INR < 2.0 more than 50% of the time.
Review: Palareti G, Legnani C, Cosmi B, Guazzaloca G, Cini M, Mattarozzi S. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. J Thromb Haemost. 2005 May;3(5):955-61.
Palareti and colleagues reported on 297 patients with idiopathic venous thrombosis followed for 21 months after oral anticoagulation therapy (OAT) was stopped. Patients whose INRs were less than 1.5 the most often during the first 90 days of warfarin therapy were about 2.8 times as likely to have a recurrent venous thrombosis after OAT was stopped (relative risk 2.77, 95% confidence interval 1.49 - 5.18).
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
Click here to view full list of new postings